Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension
Explore this paper's citation graph
- Type
- article
- Published
- 2001-10-01
- Cited by
- 35
- References
- 36
- OpenAlex
- https://openalex.org/W1967504606
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30818689
Keywords
Metformin, Medicine, Internal medicine, Placebo, Endocrinology
References
- Hyperleptinaemia: the Missing Link in the Metabolic Syndrome?
- Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats.
- Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.
- Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
- Vascular effects of metformin. Possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat.
- Short‐term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.
- Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects.
- Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
- Effects of Calcium Antagonists on Glucose Homeostasis and Serum Lipids in Non-Diabetic and Diabetic Subjects: A Review
- The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients
- Clinical review 94: What's in a name? In search of leptin's physiologic role.
- The Effects of High- and Medium-Dose Metformin Therapy on Cardiovascular Risk Factors in Patients With Type II Diabetes
- Metformin's Effects on Glucose and Lipid Metabolism in Patients with Secondary Failure to Sulfonylureas
- Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.
- Hypertension in Obesity and NIDDM: Role of Insulin and Sympathetic Nervous System
- Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity.
- Relationships Between Plasma Leptin and Insulin Concentrations, But Not Insulin Resistance, in Non‐insulin‐Dependent (Type 2) Diabetes Mellitus
- Epidemiology of Hypertension Associated with Diabetes Mellitus
- Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women
Cited by
- Effect of Metformin on Blood Pressure
- Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
- The antidiabetic activity of the herbal preparation ADD-199 in mice: a comparative study with two oral hypoglycaemic drugs.
- Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury.
- Metformin increases plasma ghrelin in Type 2 diabetes.
- [Metformin for type-2 diabetes mellitus. Systematic review and meta-analysis].
- Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke
- MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
- Do effects on blood pressure contribute to improved clinical outcomes with metformin?
- Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
- WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.
- Ambulatory Blood Pressure and the Metabolic Syndrome in Normotensive and Untreated Hypertensive Men
- Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
- Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
- Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes.
- Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
- Metformin for Treatment of Antipsychotic-Induced Amenorrhea in Female Schizophrenic Patients: Report of Two Cases
- METFORMIN: NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS.
- [Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)--preliminary study].
- Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus
Related papers
- Metformin for Prevention of Type 2 Diabetes
- A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity
- Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
- Advances in the study on metformin beyond its hypoglycemic effect
- General Study on Metformin
- P-54 : 중환자실 입실 전 투여된 metformin 이 급성 호흡곤란 증후군 환자의 예후에 미치는 영향
- Metformin and cancer.
- Metformin and metabolic diseases： a focus on hepatic aspects
- 359 MORTALITY RATES IN METFORMIN USERS VERSUS NON-METFORMIN USERS IN VETERANS WITH TYPE 2 DIABETES MELLITUS.